Let's schedule your Medical Weight Loss Consultation today!
Pharmacological and Lipotropic Weight-loss
Semaglutide
Semaglutide is a medication that belongs to a class of drugs known as GLP-1 receptor agonists. It is used to treat type 2 diabetes by regulating blood sugar levels. Semaglutide is also FDA-approved for weight loss.
​
Semaglutide helps to lower blood sugar levels by stimulating insulin secretion and inhibiting glucagon secretion. This leads to better blood sugar control and reduced risk of complications associated with diabetes. Additionally, Semaglutide has been shown to promote weight loss in people with type 2 diabetes. This is because it reduces appetite, slows down the emptying of the stomach, and increases feelings of fullness. Semaglutide has been found to reduce the risk of cardiovascular disease, including reducing the risk of heart attacks, strokes, and other cardiovascular events. Semaglutide has been shown to reduce the risk of kidney disease in people with type 2 diabetes. This is because it helps to lower blood sugar levels, which can cause damage to the kidneys over time. Semaglutide is administered once a week by injection, which makes it more convenient than other diabetes medications that need to be taken several times a day.
Tirzepatide
​
Tirzepatide is a medication that belongs to a class of drugs known as GIP and GLP-1 receptor agonists. It is used for the treatment of type 2 diabetes and weight loss.
​
By targeting both receptors, Tirzepatide enhances insulin secretion and reduces glucagon secretion in a glucose-dependent manner, contributing to improved glycemic control. In addition to its glucose-lowering effects, tirzepatide has been associated with significant weight loss in clinical trials. This can be particularly beneficial for individuals with type 2 diabetes, as weight management is a crucial aspect of overall diabetes care. Like other newer diabetes medications, tirzepatide has undergone cardiovascular outcomes trials. These trials assess the impact of the medication on cardiovascular events, providing valuable information on the safety and potential cardiovascular benefits of the drug.
This weight management protocol is a physician supervised program designed to help any individual reach his or her specific weight loss goals. The weight management protocol uses a combination of Naltrexone, Sermorelin, Lipo-Trim SL and low-calorie intake to achieve optimum weight loss results. The protocol may also boost metabolism and help patients lose large amounts of fat, all without feeling hungry.